Gene alterations in BTG2, PIM1, DUSP2, ETV6 and CXCR4 had been identified in more than 20% of patients with primary CNS lymphoma (PCNSL) in a study by Wang and colleagues [36]. This evidence concerns the gene DUSP2 and primary central nervous system lymphoma.